{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for valproic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:miromavimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01905475: Phase 2 Interventional Completed Large Reperfused ST-Elevation Myocardial Infarction
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:betinukibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:docaravimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:demupitamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02772822: Phase 3 Interventional Unknown status Diffuse Large B Cell Lymphoma
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ligufalimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efpegerglucagon [INN]
Source URL:
Class:
PROTEIN
